On the other hand, the 10 cases identified as carrying homo- and heterozygous deletions of CDKN2A were segregated into 7 cases of MPM (70%) and 3 individuals with familial melanoma (FM, 30%). This evidence concerns the gene CDKN2A and familial melanoma.